Stability Influences the Biodistribution, Toxicity, and Anti-tumor Activity of Doxorubicin Encapsulated in PEG-PE Micelles in Mice
- 17 March 2012
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 29 (7) , 1977-1989
Abstract
To investigate the influences of stability of doxorubicin (DOX) retained in PEG-PE/HSPC micelles on its biodistribution, toxicity and anti-tumor activity in mice.Keywords
This publication has 29 references indexed in Scilit:
- Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicinBiomaterials, 2010
- Nanoparticle therapeutics: an emerging treatment modality for cancerNature Reviews Drug Discovery, 2008
- Doxorubicin, Cardiac Risk Factors, and Cardiac Toxicity in Elderly Patients With Diffuse B-Cell Non-Hodgkin's LymphomaJournal of Clinical Oncology, 2008
- Nanocarriers as an emerging platform for cancer therapyNature Nanotechnology, 2007
- Protective Effects of Erdosteine on Doxorubicin-induced Hepatotoxicity in RatsArchives of Medical Research, 2007
- Detailed Structure of Hairy Mixed Micelles Formed by Phosphatidylcholine and PEGylated Phospholipids in Aqueous MediaLangmuir, 2005
- In vitro characterization of PEGylated phospholipid micelles for improved drug solubilization: Effects of PEG chain length and PC incorporationJournal of Pharmaceutical Sciences, 2004
- Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancerBiochimica et Biophysica Acta (BBA) - Biomembranes, 2004
- Glomerular permeability and polyanion in Adriamycin nephrosis in the ratKidney International, 1983
- Adriamycin-induced myocardial lesions Report of a WorkshopAmerican Journal of Surgical Pathology, 1977